Month: May 2024

Results Exceeded all Guided Metrics Subscription Portion of Annual Recurring Revenue (ARR) Grew 54% Year-Over-Year to $621 million Total ARR...

OPELOUSAS, La., May 2, 2024 /PRNewswire/ -- Catalyst Bancorp, Inc. (Nasdaq: "CLST") (the "Company"), the parent company for Catalyst Bank (the...

ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD,...

Multiple preclinical and clinical abstracts accepted for presentation at 2024 ASCO Annual Meeting and AACR Annual Meeting underscore breadth of...

First BTK inhibitor to show favorable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting Contacts Media Inquiries Brendan...

ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing...

LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, and...

LONDON, May 02, 2024 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, and...

MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the first quarter ended...

DUBLIN, May 2, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and...

– Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now...

RAMSEY, N.J. and BOCA RATON, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the...

STATEN ISLAND, N.Y., May 2, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage...

Conference call and webcast at 8:30am ET Contacts Allison Wey Senior Vice President, Investor Relations and Corporate Communications awey@xerispharma.com Xeris...

DUBLIN, Ohio, May 2, 2024 /PRNewswire/ -- The Wendy's Company (Nasdaq: WEN) today reported unaudited results for the first quarter...

Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile...

Total Revenue of $1,096 million GAAP Diluted EPS $0.50, Non-GAAP Diluted EPS1 $0.79 Contacts Investor Contact: Jeff Chesnut SVP Strategy...

OKLAHOMA CITY, May 2, 2024 /PRNewswire/ -- Mammoth Energy Services, Inc. ("Mammoth" or the "Company") (NASDAQ: TUSK) today reported financial...

TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer...

Andy Youé joins Wavelo to scale sales organization, accelerating the mission to help operators globally increase revenue and decrease costs TORONTO,...

- Completed additional enrollment in Phase 1B dose-expansion cohorts for TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) patients in the...

CLEVELAND, May 02, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global...

Contacts Investor Relations Contact Dean Pohl Rimini Street, Inc. +1 925 523-7636 dpohl@riministreet.com Media Relations Contact Janet Ravin Rimini Street,...

Company to Continue Investment in Hardware, Software and Content Innovation, Improvements to Member Support Experience, and Marketing Optimization to Scale...

HAIFA, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or the “Company”), a leading biotechnology company...

Contacts Mike Nieves SVP, Finance & Treasurer PENN Entertainment 610-373-2400 Joseph N. Jaffoni, Richard Land JCIR 212-835-8500 or penn@jcir.com PENN...

Origin’s manufacturing system is expected to produce the first commercial-scale PET caps and closures Origin’s sustainable PET caps and closures...

Origin’s manufacturing system is expected to produce the first commercial-scale PET caps and closures Origin’s sustainable PET caps and closures...

Fiscal Second Quarter 2024 HighlightsBUFORD, Ga., May 02, 2024 (GLOBE NEWSWIRE) -- OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater” or the...

Quarterly net revenues of $139 million, up 13% year-over-year, with 3,845 active patients on therapy as of March 31, 2024...

LOUDON, Tenn., May 02, 2024 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) today announced its financial results for the...

First Quarter 2024BEDFORD, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the Company) (NASDAQ: LNTH), the leading radiopharmaceutical-focused...

Adjusted EBITDA(1) growth of 5% YOYDigital-only subscription revenue increased 48%(2) with subscriptions up 25%Total Digital Revenue(3) of $71M represented 48%...

KT-474/SAR444656 (IRAK4) Phase 2 clinical trials ongoing in HS and AD with data expected in the first half of 2025KT-621 (STAT6)...

PITTSBURGH, May 02, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today...

Company Announces Share Repurchase Program of Up to 8.37 Million Shares; and Appoints New Chairman of the Board of Directors...

-- Record First Quarter Results Represent a Strong Start to 2024 -- -- Re-affirms Full Year Guidance -- First Quarter...

Earnings Release Highlights GAAP Net Income of $0.66 per share and Adjusted (non-GAAP) Operating Earnings of $0.68 per share for...

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced...

TEL AVIV, Israel, May 02, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company...